Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

Drug compounders are moving to block the FDA’s decision that Novo Nordisk A/S’s weight loss drug is no longer in shortage, ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Student scientists have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

LONDON (Reuters) -Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...